Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Mid-range Performer
1462.8000
-22.80
(
-1.53
%)
NSE
Jan 23, 2026
15:31 PM
25.22% Gain from 52W Low
Volume:
47,636
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
12 Aug 2023
1462.80
-1.53%
Domestic formulation drives earnings
Neutral:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 840
Target
Motilal Oswal
Number of FII/FPI investors decreased from 254 to 248 in Dec 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
Five Interesting Stocks Today - January 23, 2026
The Baseline |
23 Jan 2026
Market closes lower as the rupee hits a record low
Trendlyne Marketwatch |
23 Jan 2026
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021